UiPath Inc.’s recent earnings beat and raise provides some evidence that thus far, generative artificial intelligence has not been dilutive for the company. As an early leader that is transforming ...

In boardrooms and IT departments alike, a hard truth is setting in: most so-called “smart assistants” aren’t built for the messy, unpredictable world of the enterprise. While conversational bots and ...

NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced new agentic AI solutions for the healthcare industry for providers and payers at the ViVE 2026 ...

UiPath Inc. is rated a strong buy, with a price target near $18, following a 30% sell-off driven by AI-related sector fears. PATH's robust AI-driven automation platform, strong earnings beats, and 16% ...

UiPath now represents 2.17% of AUM, making it the fund's 4th-largest holding BW Gestao de Investimentos Ltda. disclosed a substantial buy in UiPath on its November 13, 2025, SEC filing, increasing its ...